C429-0373 Screening compound: ethyl 4-(1-{[4-(diethylsulfamoyl)phenyl]amino}-3-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-1-carboxylate

C429-0373 Screening compound: ethyl 4-(1-{[4-(diethylsulfamoyl)phenyl]amino}-3-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-1-carboxylate
C429-0373 Screening compound: ethyl 4-(1-{[4-(diethylsulfamoyl)phenyl]amino}-3-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-1-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound C429-0373
ethyl 4-(1-{[4-(diethylsulfamoyl)phenyl]amino}-3-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-1-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C429-0373

Molecular Formula

C26H34N4O5S (C26 H34 N4 O5 S)

Compound Name

ethyl 4-(1-{[4-(diethylsulfamoyl)phenyl]amino}-3-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-1-carboxylate

IUPAC name

ethyl 4-(1-{[4-(diethylsulfamoyl)phenyl]amino}-3-oxo-23-dihydro-1H-isoindol-2-yl)piperidine-1-carboxylate

SMILES

CCN(CC)S(c(cc1)ccc1NC(c1c2cccc1)N(C(CC1)CCN1C(OCC)=O)C2=O)(=O)=O

InChI

InChI=1S/C26H34N4O5S/c1-4-29(5-2)36(33,34)21-13-11-19(12-14-21)27-24-22-9-7-8-10-23(22)25(31)30(24)20-15-17-28(18-16-20)26(32)35-6-3/h7-14,20,24,27H,4-6,15-18H2,1-3H3/t24-/m0/s1

InChI Key

RRJGXSSZTXCQQA-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD14756112

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

514.65

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.855

Distribution Coefficient, logD

3.855

Water Solubility, LogSw

-3.90

Polar Surface Area

78.100

Acid Dissociation Constant (pKa)

15.46

Base Dissociation Constant (pKb)

0.53

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

46.20

C429-0373 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C429-0373 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C429-0373?
Check Price and Availability of C429-0373, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C429-0373 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C429-0373
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C429-0373
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C429-0373 available by request